Advertisement

Topics

BRIEF-Cerulean announces $20 mln firm commitment at-the-market stock purchase agreement with Aspire Capital Fund

04:19 EDT 19 Oct 2016 | Reuters

* Cerulean announces $20 million firm commitment at-the-market stock purchase agreement with Aspire Capital Fund

Original Article: BRIEF-Cerulean announces $20 mln firm commitment at-the-market stock purchase agreement with Aspire Capital Fund

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Cerulean announces $20 mln firm commitment at-the-market stock purchase agreement with Aspire Capital Fund"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...